Company: SRPT
Filing Date: 2025-04-24
Form Type: DEF 14A
Source: 0000950170-25-058003
Chunk: 56

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-04-24
Form: DEF 14A
Chunk 56
---
 of our common stock subject to options exercisable within 60 days of April 8, 2025. Such shares are subject to a one-year holding period upon exercise.

Includes 248,967 shares of our common stock subject to options exercisable within 60 days of April 8, 2025.

Includes 274,492 shares of our common stock subject to options exercisable within 60 days of April 8, 2025.

Includes 71,318 shares of our common stock subject to options exercisable within 60 days of April 8, 2025.

Includes 174,635 shares of our common stock subject to options exercisable within 60 days of April 8, 2025.

Includes 3,241,162 shares of our common stock subject to options exercisable within 60 days of April 8, 2025.

Includes 46,200 shares of our common stock subject to options exercisable within 60 days of April 8, 2025.

Based solely on information contained in the Schedule 13G/A filed with the SEC on June 7, 2024, reporting beneficial ownership of BlackRock, Inc. BlackRock Inc. has sole voting power of 9,898,523 shares of our common stock and sole dispositive power of 10,124,431 shares of our common stock.

Based solely on information contained in the Schedule 13G/A filed with the SEC on February 14, 2025, reporting beneficial ownership of Capital International Investors. Capital International Investors has sole voting power of 8,879,638 shares of our common stock and sole dispositive power of 8,896,223 shares of our common stock.

Based solely on information contained in the Schedule 13G/A filed with the SEC on February 13, 2024, reporting beneficial ownership of The Vanguard Group. The Vanguard Group has shared voting power of 36,267 shares of our common stock, sole dispositive power over 8,688,629 shares of our common stock and shared dispositive power over 127,495 shares of our common stock.

<div align='center'>THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK.

33</div>

Equity Compensatio n Plan Information The table below summarizes information, as of December 31, 2024, with respect to shares of our common stock that may be issued under our equity plans:

| Plan Category                                             |     | Number of      
 securities to  
 be issued upon